General Anesthetic [EPC]

General Anesthetic [EPC] was reported 43600 times

These side effects are most commonly reported by patients taking drugs of the General Anesthetic [EPC] class:

# Drug class Count
0 HYPOTENSION 3377
1 DRUG INEFFECTIVE 3257
2 ANAPHYLACTIC SHOCK 2289
3 CARDIAC ARREST 2191
4 OFF LABEL USE 1921
5 ANAPHYLACTIC REACTION 1849
6 DRUG INTERACTION 1793
7 BRADYCARDIA 1515
8 TACHYCARDIA 1381
9 RENAL FAILURE 1129
10 PYREXIA 1116
11 ACUTE KIDNEY INJURY 1089
12 RHABDOMYOLYSIS 1034
13 PAIN 1006
14 OXYGEN SATURATION DECREASED 975
15 BRONCHOSPASM 953
16 TOXICITY TO VARIOUS AGENTS 872
17 RESPIRATORY FAILURE 870
18 NAUSEA 826
19 SEROTONIN SYNDROME 805
20 HYPOXIA 801
21 VOMITING 797
22 DYSPNOEA 794
23 RASH 762
24 BLOOD PRESSURE DECREASED 760
25 ANXIETY 754
26 DEATH 732
27 METABOLIC ACIDOSIS 713
28 RENAL IMPAIRMENT 702
29 CONDITION AGGRAVATED 686
30 FOETAL EXPOSURE DURING PREGNANCY 668
31 PRODUCT USE IN UNAPPROVED INDICATION 664
32 PNEUMONIA 663
33 HYPERTENSION 659
34 INJURY 643
35 PROPOFOL INFUSION SYNDROME 634
36 ERYTHEMA 630
37 HYPERTHERMIA MALIGNANT 625
38 ANAESTHETIC COMPLICATION NEUROLOGICAL 621
39 AGITATION 615
40 STATUS EPILEPTICUS 607
41 OVERDOSE 597
42 SEPSIS 596
43 CIRCULATORY COLLAPSE 577
44 MATERNAL EXPOSURE DURING PREGNANCY 543
45 URTICARIA 538
46 SEIZURE 530
47 UNEVALUABLE EVENT 530
48 RENAL FAILURE ACUTE 524
49 VENTRICULAR TACHYCARDIA 509
50 MULTI-ORGAN FAILURE 505
51 RESPIRATORY DEPRESSION 500
52 CARDIO-RESPIRATORY ARREST 498
53 EMOTIONAL DISTRESS 498
54 HYPERKALAEMIA 495
55 THROMBOCYTOPENIA 495
56 ATRIAL FIBRILLATION 490
57 POST PROCEDURAL COMPLICATION 487
58 SHOCK 484
59 VENTRICULAR FIBRILLATION 483
60 MULTIPLE ORGAN DYSFUNCTION SYNDROME 478
61 SOMNOLENCE 478
62 BLOOD CREATINE PHOSPHOKINASE INCREASED 469
63 PULMONARY OEDEMA 466
64 FEAR 459
65 CHILLS 455
66 DRUG HYPERSENSITIVITY 451
67 ELECTROCARDIOGRAM QT PROLONGED 439
68 SEPTIC SHOCK 435
69 COMA 426
70 ALANINE AMINOTRANSFERASE INCREASED 425
71 HAEMODYNAMIC INSTABILITY 422
72 DELAYED RECOVERY FROM ANAESTHESIA 416
73 RENAL INJURY 409
74 CONFUSIONAL STATE 408
75 LOSS OF CONSCIOUSNESS 406
76 ASTHENIA 391
77 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 391
78 DEPRESSED LEVEL OF CONSCIOUSNESS 390
79 RESPIRATORY ARREST 382
80 ANAEMIA 381
81 HYPERSENSITIVITY 377
82 EXPOSURE DURING PREGNANCY 373
83 HEADACHE 371
84 PREMATURE BABY 371
85 MYOCLONUS 367
86 COUGH 366
87 DIARRHOEA 364
88 UNRESPONSIVE TO STIMULI 357
89 ANAESTHETIC COMPLICATION 348
90 ASPARTATE AMINOTRANSFERASE INCREASED 344
91 ANHEDONIA 341
92 STRESS 340
93 HEART RATE INCREASED 338
94 DELIRIUM 335
95 DIZZINESS 325
96 DEPRESSION 324
97 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 316
98 STRESS CARDIOMYOPATHY 312
99 ACUTE RESPIRATORY DISTRESS SYNDROME 305
100 FATIGUE 305
101 HEPATIC FAILURE 305
102 APNOEA 302
103 ANGIOEDEMA 299
104 BLOOD PRESSURE INCREASED 297
105 CONVULSION 297
106 ENCEPHALOPATHY 295
107 ABDOMINAL PAIN 291
108 CARDIAC FAILURE 287
109 TOXIC EPIDERMAL NECROLYSIS 287
110 ARRHYTHMIA 284
111 HAEMORRHAGE 283
112 RESPIRATORY ACIDOSIS 281
113 RESPIRATORY DISTRESS 281
114 COAGULOPATHY 280
115 DYSKINESIA 278
116 BLOOD CREATININE INCREASED 277
117 LACTIC ACIDOSIS 275
118 DYSTONIA 270
119 TREMOR 269
120 TORSADE DE POINTES 268
121 PRURITUS 267
122 PLEURAL EFFUSION 265
123 GENERALISED TONIC-CLONIC SEIZURE 260
124 DRUG ABUSE 259
125 HYPERHIDROSIS 256
126 PULSELESS ELECTRICAL ACTIVITY 252
127 CARDIOGENIC SHOCK 251
128 BRAIN OEDEMA 248
129 TACHYPNOEA 248
130 BACK PAIN 247
131 HYPOKALAEMIA 245
132 GENERAL PHYSICAL HEALTH DETERIORATION 243
133 PULMONARY EMBOLISM 243
134 ACUTE RESPIRATORY FAILURE 242
135 SINUS TACHYCARDIA 242
136 MEDICATION ERROR 241
137 MYOCARDIAL INFARCTION 237
138 PROCEDURAL COMPLICATION 237
139 MUSCULAR WEAKNESS 233
140 CEREBROVASCULAR ACCIDENT 232
141 MALAISE 231
142 COMPLETED SUICIDE 230
143 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 227
144 MUSCLE RIGIDITY 227
145 DIABETES INSIPIDUS 226
146 HAEMOGLOBIN DECREASED 225
147 CYANOSIS 224
148 HYPERTHERMIA 223
149 HEART RATE DECREASED 219
150 PNEUMONIA ASPIRATION 219
151 DISSEMINATED INTRAVASCULAR COAGULATION 218
152 RASH MACULO-PAPULAR 218
153 GASTROINTESTINAL HAEMORRHAGE 215
154 LARYNGOSPASM 212
155 HEPATITIS 207
156 VENTRICULAR EXTRASYSTOLES 207
157 HYPERCAPNIA 205
158 CHEST PAIN 201
159 DYSPHAGIA 198
160 PREMATURE DELIVERY 198
161 ACUTE HEPATIC FAILURE 197
162 PRODUCT USE ISSUE 197
163 WHEEZING 196
164 FALL 194
165 MYALGIA 194
166 MYDRIASIS 193
167 PRODUCT QUALITY ISSUE 192
168 WEIGHT DECREASED 190
169 PLATELET COUNT DECREASED 189
170 ABDOMINAL DISTENSION 188
171 INTENTIONAL OVERDOSE 186
172 BLOOD BILIRUBIN INCREASED 185
173 HYPERTRIGLYCERIDAEMIA 184
174 ATELECTASIS 182
175 HEPATOCELLULAR INJURY 182
176 INTESTINAL ISCHAEMIA 182
177 DEEP VEIN THROMBOSIS 179
178 HEPATIC FUNCTION ABNORMAL 178
179 MULTIPLE-DRUG RESISTANCE 178
180 DRUG-INDUCED LIVER INJURY 177
181 INFECTION 177
182 LEUKOCYTOSIS 176
183 ACIDOSIS 175
184 NEUROLEPTIC MALIGNANT SYNDROME 175
185 PANCREATITIS 175
186 FLUSHING 174
187 NEUROMUSCULAR BLOCK PROLONGED 174
188 NEUTROPENIA 173
189 SINUS BRADYCARDIA 171
190 URINARY TRACT INFECTION 171
191 ARTERIOSPASM CORONARY 170
192 PANCREATITIS ACUTE 170
193 CONSTIPATION 169
194 CHOLESTASIS 167
195 CHRONIC KIDNEY DISEASE 166
196 HYPOVENTILATION 166
197 MENTAL STATUS CHANGES 166
198 UNWANTED AWARENESS DURING ANAESTHESIA 166
199 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 165
200 LOW BIRTH WEIGHT BABY 164
201 INSOMNIA 163
202 DISORIENTATION 162
203 EOSINOPHILIA 162
204 OEDEMA PERIPHERAL 162
205 PNEUMOTHORAX 162
206 PROCEDURAL HYPOTENSION 162
207 TREATMENT FAILURE 161
208 DRUG EXPOSURE DURING PREGNANCY 158
209 PULMONARY ALVEOLAR HAEMORRHAGE 158
210 SUICIDE ATTEMPT 158
211 ALTERED STATE OF CONSCIOUSNESS 157
212 DEHYDRATION 157
213 DRUG WITHDRAWAL SYNDROME 157
214 NO ADVERSE EVENT 157
215 ATRIOVENTRICULAR BLOCK COMPLETE 156
216 EPILEPSY 156
217 BLOOD LACTATE DEHYDROGENASE INCREASED 155
218 RASH ERYTHEMATOUS 155
219 HEPATIC ENZYME INCREASED 154
220 JAUNDICE 154
221 RESPIRATORY DISORDER 154
222 STEVENS-JOHNSON SYNDROME 154
223 GAIT DISTURBANCE 153
224 HEPATIC CYTOLYSIS 153
225 PAIN IN EXTREMITY 153
226 HYPERGLYCAEMIA 152
227 AGGRESSION 151
228 PARAESTHESIA 150
229 THERAPY NON-RESPONDER 149
230 MUSCLE SPASMS 147
231 FACE OEDEMA 146
232 BLOOD LACTIC ACID INCREASED 145
233 DRUG EFFECT DECREASED 145
234 ACUTE PULMONARY OEDEMA 144
235 BODY TEMPERATURE INCREASED 144
236 OEDEMA 144
237 PULSE ABSENT 144
238 SHOCK HAEMORRHAGIC 144
239 HYPONATRAEMIA 143
240 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 142
241 COGNITIVE DISORDER 141
242 TRANSAMINASES INCREASED 141
243 ARTHRALGIA 140
244 GENERALISED ERYTHEMA 140
245 SUPRAVENTRICULAR TACHYCARDIA 140
246 CEREBRAL HAEMORRHAGE 139
247 CHROMATURIA 136
248 HYPOAESTHESIA 136
249 HYPOTHERMIA 135
250 ELECTROENCEPHALOGRAM ABNORMAL 134
251 ASCITES 133
252 OLIGURIA 133
253 RESTLESSNESS 132
254 ABDOMINAL PAIN UPPER 131
255 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 130
256 KOUNIS SYNDROME 130
257 OBSTRUCTIVE AIRWAYS DISORDER 130
258 LIVER DISORDER 129
259 LIVER INJURY 129
260 HEPATOTOXICITY 128
261 APHASIA 127
262 SYNCOPE 127
263 PARALYSIS 126
264 DECREASED APPETITE 125
265 CARDIAC FAILURE CONGESTIVE 124
266 HAEMATURIA 124
267 PANCYTOPENIA 124
268 THERAPEUTIC PRODUCT EFFECT DECREASED 124
269 TROPONIN INCREASED 124
270 POST PROCEDURAL HAEMORRHAGE 123
271 ACUTE MYOCARDIAL INFARCTION 122
272 SEDATION 122
273 ATRIOVENTRICULAR BLOCK 121
274 BLOOD POTASSIUM INCREASED 121
275 CARDIOVASCULAR DISORDER 121
276 MYOCARDIAL ISCHAEMIA 121
277 PARTIAL SEIZURES 121
278 HAEMATEMESIS 120
279 INTENTIONAL PRODUCT MISUSE 120
280 LARYNGEAL OEDEMA 119
281 LIVER FUNCTION TEST ABNORMAL 119
282 BRAIN INJURY 118
283 HAEMOPTYSIS 118
284 CLONUS 117
285 HAEMODIALYSIS 117
286 RENAL TUBULAR NECROSIS 117
287 HEPATITIS C 116
288 HYPOVOLAEMIA 116
289 AMNESIA 115
290 ANAPHYLACTOID REACTION 115
291 HYPERNATRAEMIA 115
292 PALLOR 115
293 WHITE BLOOD CELL COUNT INCREASED 115
294 DYSARTHRIA 114
295 MEMORY IMPAIRMENT 114
296 ASPIRATION 112
297 ILEUS 112
298 STRIDOR 112
299 VASOPLEGIA SYNDROME 112
300 ANURIA 111
301 BLOOD ALKALINE PHOSPHATASE INCREASED 111
302 ACCIDENTAL OVERDOSE 110
303 CARDIAC DISORDER 110
304 DRUG RESISTANCE 110
305 FEBRILE NEUTROPENIA 110
306 GASTROOESOPHAGEAL REFLUX DISEASE 110
307 TYPE I HYPERSENSITIVITY 110
308 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 109
309 HALLUCINATION 109
310 POLYURIA 109
311 SPEECH DISORDER 108
312 HYPOTONIA 107
313 NERVOUS SYSTEM DISORDER 107
314 TOXIC ENCEPHALOPATHY 107
315 LEUKOPENIA 106
316 MUSCLE TWITCHING 106
317 SWELLING FACE 106
318 ASTHMA 105
319 CEREBRAL INFARCTION 105
320 HYPOGLYCAEMIA 105
321 EPISTAXIS 104
322 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 104
323 INCORRECT DOSE ADMINISTERED 104
324 HYPERBILIRUBINAEMIA 103
325 NEUROTOXICITY 102
326 C-REACTIVE PROTEIN INCREASED 101
327 CAESAREAN SECTION 101
328 VENTRICULAR ARRHYTHMIA 101
329 AIRWAY COMPLICATION OF ANAESTHESIA 100
330 EJECTION FRACTION DECREASED 100
331 HEPATITIS ACUTE 100
332 HYPERTENSIVE CRISIS 100
333 LEFT VENTRICULAR DYSFUNCTION 100
334 PULMONARY HYPERTENSION 100
335 GRAND MAL CONVULSION 99
336 INTERSTITIAL LUNG DISEASE 99
337 MATERNAL EXPOSURE DURING DELIVERY 99
338 SWOLLEN TONGUE 99
339 BLOOD TRIGLYCERIDES INCREASED 98
340 DRUG DEPENDENCE 98
341 CHEST DISCOMFORT 97
342 LETHARGY 97
343 URINARY RETENTION 97
344 INTENTIONAL PRODUCT USE ISSUE 96
345 OROPHARYNGEAL PAIN 96
346 SEDATION COMPLICATION 96
347 BLOOD GLUCOSE INCREASED 95
348 COVID-19 95
349 GAMMA-GLUTAMYLTRANSFERASE INCREASED 94
350 STAPHYLOCOCCAL INFECTION 94
351 THROMBOSIS 93
352 DRUG LEVEL INCREASED 92
353 NYSTAGMUS 92
354 CARDIOMEGALY 91
355 VISION BLURRED 91
356 DRUG TOXICITY 90
357 MOTOR DYSFUNCTION 90
358 WITHDRAWAL SYNDROME 89
359 CARDIOMYOPATHY 88
360 PRODUCT CONTAMINATION 88
361 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 88
362 DISEASE PROGRESSION 87
363 OSTEOARTHRITIS 87
364 EXTRAPYRAMIDAL DISORDER 86
365 VENTRICULAR HYPOKINESIA 86
366 ENDOTRACHEAL INTUBATION 85
367 FEELING ABNORMAL 85
368 PALPITATIONS 85
369 CELLULITIS 84
370 MOVEMENT DISORDER 84
371 MUSCULOSKELETAL STIFFNESS 84
372 ANTICHOLINERGIC SYNDROME 83
373 HAEMATOMA 83
374 INFLAMMATION 83
375 NO THERAPEUTIC RESPONSE 83
376 PROCEDURAL PAIN 83
377 BRAIN HERNIATION 82
378 HYPERREFLEXIA 82
379 LIVER FUNCTION TEST INCREASED 82
380 LUNG DISORDER 82
381 PCO2 INCREASED 82
382 URINARY INCONTINENCE 82
383 URINE OUTPUT DECREASED 82
384 AGRANULOCYTOSIS 81
385 BLOOD PH DECREASED 81
386 LIP SWELLING 81
387 PRODUCT CONTAMINATION MICROBIAL 81
388 RASH GENERALISED 81
389 CONTRAINDICATED PRODUCT ADMINISTERED 80
390 SINUS ARREST 80
391 SWELLING 80
392 AMYLASE INCREASED 79
393 DIALYSIS 79
394 EXTRASYSTOLES 79
395 TREATMENT NONCOMPLIANCE 79
396 VISUAL IMPAIRMENT 79
397 BLOOD CALCIUM DECREASED 78
398 BLOOD UREA INCREASED 78
399 COVID-19 PNEUMONIA 78
400 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 78
401 BLISTER 77
402 FOETAL DEATH 77
403 METHAEMOGLOBINAEMIA 77
404 HYPERLIPIDAEMIA 76
405 INTERNATIONAL NORMALISED RATIO INCREASED 76
406 LABILE BLOOD PRESSURE 76
407 PULMONARY CONGESTION 76
408 WHITE BLOOD CELL COUNT DECREASED 76
409 ACCIDENTAL EXPOSURE TO PRODUCT 75
410 BLOOD PRESSURE SYSTOLIC DECREASED 75
411 LUNG INFILTRATION 75
412 THERAPEUTIC RESPONSE DECREASED 75
413 WEIGHT INCREASED 75
414 BRAIN DEATH 74
415 END STAGE RENAL DISEASE 74
416 NEGATIVE PRESSURE PULMONARY OEDEMA 74
417 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 74
418 TRYPTASE INCREASED 74
419 DIABETES MELLITUS 73
420 HEPARIN-INDUCED THROMBOCYTOPENIA 73
421 MITRAL VALVE INCOMPETENCE 73
422 MYOGLOBIN URINE PRESENT 73
423 SEIZURE LIKE PHENOMENA 73
424 AUTONOMIC NERVOUS SYSTEM IMBALANCE 72
425 BACTERAEMIA 72
426 CORONARY ARTERY DISEASE 72
427 EXTRAVASATION 72
428 HYPERAMMONAEMIA 72
429 NEPHROGENIC DIABETES INSIPIDUS 72
430 AIRWAY PEAK PRESSURE INCREASED 71
431 ELECTROCARDIOGRAM ABNORMAL 71
432 RESUSCITATION 71
433 HYPOCALCAEMIA 70
434 TUBULOINTERSTITIAL NEPHRITIS 70
435 ATRIOVENTRICULAR BLOCK SECOND DEGREE 69
436 HYPOMAGNESAEMIA 69
437 SLEEP DISORDER 69
438 HYPERTONIA 68
439 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 68
440 WRONG TECHNIQUE IN DRUG USAGE PROCESS 68
441 CARDIAC FAILURE ACUTE 67
442 CHOLELITHIASIS 66
443 IRRITABILITY 66
444 PSEUDOMONAS INFECTION 66
445 RECURRENCE OF NEUROMUSCULAR BLOCKADE 66
446 DRUG USE DISORDER 65
447 HEPATIC STEATOSIS 65
448 INTRACRANIAL PRESSURE INCREASED 65
449 POSTOPERATIVE DELIRIUM 65
450 SALIVARY HYPERSECRETION 65
451 SUBARACHNOID HAEMORRHAGE 65
452 CARDIOTOXICITY 64
453 CYTOKINE RELEASE SYNDROME 64
454 DRUG ADMINISTRATION ERROR 64
455 FLATULENCE 64
456 NEPHROGENIC ANAEMIA 64
457 TOXIC SKIN ERUPTION 64
458 TRISMUS 64
459 ATAXIA 63
460 CEREBRAL ISCHAEMIA 63
461 CONGENITAL ANOMALY 63
462 HYPERLACTACIDAEMIA 63
463 MENTAL DISORDER 63
464 PERIORBITAL OEDEMA 63
465 PSYCHOTIC DISORDER 63
466 THROMBOTIC MICROANGIOPATHY 63
467 ADRENAL INSUFFICIENCY 62
468 DRUG ERUPTION 62
469 FLUID OVERLOAD 62
470 HEPATITIS FULMINANT 62
471 KLEBSIELLA INFECTION 62
472 LEFT VENTRICULAR HYPERTROPHY 62
473 PERIPHERAL SWELLING 62
474 PRIAPISM 62
475 PULMONARY HAEMORRHAGE 62
476 BLOOD PRESSURE SYSTOLIC INCREASED 61
477 ELECTROMECHANICAL DISSOCIATION 61
478 HAEMATOCRIT DECREASED 61
479 HYPERVENTILATION 61
480 HYPOALBUMINAEMIA 61
481 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 61
482 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 61
483 MIGRAINE 61
484 SKIN TEST POSITIVE 61
485 AREFLEXIA 60
486 BLOOD ALBUMIN DECREASED 60
487 BRADYCARDIA FOETAL 60
488 INCORRECT ROUTE OF DRUG ADMINISTRATION 60
489 MOBILITY DECREASED 60
490 NECROSIS ISCHAEMIC 60
491 PROCEDURAL HAEMORRHAGE 60
492 ULCER 60
493 BRUGADA SYNDROME 59
494 DISTURBANCE IN ATTENTION 59
495 ELECTROLYTE IMBALANCE 59
496 HEMIPARESIS 59
497 ISCHAEMIC CEREBRAL INFARCTION 59
498 METABOLIC DISORDER 59
499 PERICARDIAL EFFUSION 59
500 PSYCHOMOTOR HYPERACTIVITY 59
501 TACHYARRHYTHMIA 59
502 TRIGEMINO-CARDIAC REFLEX 59
503 BLOOD BICARBONATE DECREASED 58
504 BLOOD POTASSIUM DECREASED 58
505 CATATONIA 58
506 DIPLOPIA 58
507 DISABILITY 58
508 GENERALISED OEDEMA 58
509 INCREASED BRONCHIAL SECRETION 58
510 INFLUENZA LIKE ILLNESS 58
511 NEUROPATHY PERIPHERAL 58
512 NORMAL NEWBORN 58
513 RESPIRATORY RATE INCREASED 58
514 UPPER AIRWAY OBSTRUCTION 58
515 ABDOMINAL DISCOMFORT 57
516 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 57
517 ANAPHYLACTOID SHOCK 57
518 BLOOD PRESSURE IMMEASURABLE 57
519 EYELID OEDEMA 57
520 HYPOTHYROIDISM 57
521 NEUROMUSCULAR BLOCKADE 57
522 CYTOLYTIC HEPATITIS 56
523 NON-CARDIOGENIC PULMONARY OEDEMA 56
524 PROCEDURAL NAUSEA 56
525 RASH MACULAR 56
526 RASH PRURITIC 56
527 BLOOD PRESSURE FLUCTUATION 55
528 ENCEPHALITIS 55
529 HYPOVOLAEMIC SHOCK 55
530 SUPRAVENTRICULAR EXTRASYSTOLES 55
531 TINNITUS 55
532 TRICUSPID VALVE INCOMPETENCE 55
533 DRUG INTOLERANCE 54
534 DYSPEPSIA 54
535 HYPERTRANSAMINASAEMIA 54
536 PARADOXICAL DRUG REACTION 54
537 VENTRICULAR DYSFUNCTION 54
538 ABSCESS 53
539 ADVERSE DRUG REACTION 53
540 COLITIS 53
541 DEVICE ISSUE 53
542 DISCOMFORT 53
543 DRUG LEVEL BELOW THERAPEUTIC 53
544 FEELING HOT 53
545 HEPATORENAL SYNDROME 53
546 INTESTINAL PERFORATION 53
547 MIXED LIVER INJURY 53
548 PNEUMONIA BACTERIAL 53
549 RENAL DISORDER 53
550 SPINAL OSTEOARTHRITIS 53
551 ABNORMAL BEHAVIOUR 52
552 ATRIOVENTRICULAR BLOCK FIRST DEGREE 52
553 BALANCE DISORDER 52
554 CLOSTRIDIUM DIFFICILE COLITIS 52
555 HEPATITIS CHOLESTATIC 52
556 LONG QT SYNDROME 52
557 MENTAL IMPAIRMENT 52
558 NEUROLOGICAL DECOMPENSATION 52
559 OCULOGYRIC CRISIS 52
560 SCOLIOSIS 52
561 TONIC CLONIC MOVEMENTS 52
562 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 52
563 BLOOD MAGNESIUM DECREASED 51
564 BRADYARRHYTHMIA 51
565 BUNDLE BRANCH BLOCK RIGHT 51
566 DYSPHONIA 51
567 ENDOTRACHEAL INTUBATION COMPLICATION 51
568 EYE MOVEMENT DISORDER 51
569 GASTROINTESTINAL DISORDER 51
570 MYOCARDITIS 51
571 OPISTHOTONUS 51
572 PROCEDURAL VOMITING 51
573 RECTAL HAEMORRHAGE 51
574 BUNDLE BRANCH BLOCK LEFT 50
575 DYSPNOEA EXERTIONAL 50
576 HEPATIC ENCEPHALOPATHY 50
577 HYPERAESTHESIA 50
578 INFUSION RELATED REACTION 50
579 DYSURIA 49
580 HAEMORRHOIDS 49
581 HEPATIC CIRRHOSIS 49
582 ISCHAEMIC STROKE 49
583 MECHANICAL VENTILATION COMPLICATION 49
584 MYOCLONIC EPILEPSY 49
585 PRODUCTIVE COUGH 49
586 UPPER GASTROINTESTINAL HAEMORRHAGE 49
587 DERMATITIS BULLOUS 48
588 HEPATIC NECROSIS 48
589 INJECTION SITE PAIN 48
590 LYMPHADENOPATHY 48
591 MECHANICAL VENTILATION 48
592 NERVOUSNESS 48
593 OXYGEN SATURATION ABNORMAL 48
594 PRODUCT DOSE OMISSION ISSUE 48
595 REBOUND EFFECT 48
596 RESPIRATORY RATE DECREASED 48
597 RHINORRHOEA 48
598 COMPARTMENT SYNDROME 47
599 DISEASE RECURRENCE 47
600 HIATUS HERNIA 47
601 PATENT DUCTUS ARTERIOSUS 47
602 PNEUMONITIS 47
603 SKIN DISCOLOURATION 47
604 SLEEP APNOEA SYNDROME 47
605 BRONCHITIS 46
606 BURNING SENSATION 46
607 DERMATITIS ALLERGIC 46
608 DIVERTICULITIS 46
609 GASTRITIS 46
610 HEPATOMEGALY 46
611 MALNUTRITION 46
612 MIOSIS 46
613 NODAL RHYTHM 46
614 POISONING 46
615 RALES 46
616 SUBCUTANEOUS EMPHYSEMA 46
617 CHEST X-RAY ABNORMAL 45
618 CONVERSION DISORDER 45
619 DEAFNESS NEUROSENSORY 45
620 DUODENAL ULCER 45
621 GAZE PALSY 45
622 HYPOKINESIA 45
623 HYPOPHOSPHATAEMIA 45
624 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45
625 MOOD SWINGS 45
626 OCCUPATIONAL EXPOSURE TO PRODUCT 45
627 PO2 DECREASED 45
628 POISONING DELIBERATE 45
629 APGAR SCORE LOW 44
630 ATRIAL FLUTTER 44
631 EMPHYSEMA 44
632 INCORRECT DRUG ADMINISTRATION RATE 44
633 PREMATURE LABOUR 44
634 QUALITY OF LIFE DECREASED 44
635 SURGERY 44
636 UPPER RESPIRATORY TRACT INFECTION 44
637 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44
638 ABORTION INDUCED 43
639 BLOOD GASES ABNORMAL 43
640 CARDIOVASCULAR INSUFFICIENCY 43
641 LYMPHOPENIA 43
642 MELAENA 43
643 NECROSIS 43
644 NECROTISING FASCIITIS 43
645 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 43
646 PRODUCT SUBSTITUTION ISSUE 43
647 PUPIL FIXED 43
648 SUICIDAL IDEATION 43
649 TONGUE OEDEMA 43
650 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 42
651 CONTUSION 42
652 FUNGAL INFECTION 42
653 HAEMOTHORAX 42
654 INFLUENZA 42
655 NECK PAIN 42
656 OPERATIVE HAEMORRHAGE 42
657 PARAPLEGIA 42
658 POTENTIATING DRUG INTERACTION 42
659 PROTHROMBIN TIME PROLONGED 42
660 RASH MORBILLIFORM 42
661 CARDIAC OUTPUT DECREASED 41
662 ELECTROCARDIOGRAM T WAVE INVERSION 41
663 HAEMORRHAGE INTRACRANIAL 41
664 PO2 INCREASED 41
665 RENAL ISCHAEMIA 41
666 ALLERGY TEST NEGATIVE 40
667 CARDIOPULMONARY FAILURE 40
668 HAEMATOCHEZIA 40
669 HEMIPLEGIA 40
670 INFUSION SITE EXTRAVASATION 40
671 LUNG CONSOLIDATION 40
672 RIGHT VENTRICULAR FAILURE 40
673 SINUSITIS 40
674 TORTICOLLIS 40
675 ADVERSE EVENT 39
676 ALOPECIA 39
677 DRY MOUTH 39
678 GASTRIC ULCER 39
679 HALLUCINATION, VISUAL 39
680 HORNER^S SYNDROME 39
681 HYPERVOLAEMIA 39
682 ILL-DEFINED DISORDER 39
683 MITOCHONDRIAL DNA MUTATION 39
684 MYOCARDIAL DEPRESSION 39
685 MYOGLOBIN BLOOD INCREASED 39
686 NASOPHARYNGITIS 39
687 NEW ONSET REFRACTORY STATUS EPILEPTICUS 39
688 ORGAN FAILURE 39
689 PERIPHERAL ISCHAEMIA 39
690 PERITONITIS 39
691 RENAL FAILURE CHRONIC 39
692 RETCHING 39
693 RHEUMATOID ARTHRITIS 39
694 STUPOR 39
695 THERAPEUTIC AGENT TOXICITY 39
696 WRONG PRODUCT ADMINISTERED 39
697 ACUTE CORONARY SYNDROME 38
698 AKATHISIA 38
699 ARTERIOSCLEROSIS CORONARY ARTERY 38
700 COMA SCALE ABNORMAL 38
701 DECUBITUS ULCER 38
702 DEVICE MALFUNCTION 38
703 FEAR OF DEATH 38
704 GENE MUTATION 38
705 LIP OEDEMA 38
706 MUSCLE SPASTICITY 38
707 MYOPATHY 38
708 NEUTROPHIL COUNT DECREASED 38
709 RESPIRATION ABNORMAL 38
710 SKIN EXFOLIATION 38
711 ERYTHEMA MULTIFORME 37
712 FEELING COLD 37
713 FOURNIER^S GANGRENE 37
714 HYPERPYREXIA 37
715 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 37
716 LIMB DISCOMFORT 37
717 LIPASE INCREASED 37
718 MATERNAL DRUGS AFFECTING FOETUS 37
719 PUPILLARY REFLEX IMPAIRED 37
720 RASH PAPULAR 37
721 SCREAMING 37
722 TRANSIENT ISCHAEMIC ATTACK 37
723 ACIDOSIS HYPERCHLORAEMIC 36
724 ANAESTHETIC COMPLICATION PULMONARY 36
725 ANGIOPATHY 36
726 HAEMOLYSIS 36
727 HAEMOLYTIC ANAEMIA 36
728 HEPATIC ISCHAEMIA 36
729 HYPOPNOEA 36
730 INTRA-ABDOMINAL HAEMORRHAGE 36
731 INTRA-ABDOMINAL PRESSURE INCREASED 36
732 LIVE BIRTH 36
733 MUSCULOSKELETAL PAIN 36
734 PHARMACEUTICAL PRODUCT COMPLAINT 36
735 PUPILS UNEQUAL 36
736 SUBDURAL HAEMATOMA 36
737 SUSPECTED PRODUCT CONTAMINATION 36
738 ABDOMINAL RIGIDITY 35
739 CLOSTRIDIUM DIFFICILE INFECTION 35
740 COLITIS ISCHAEMIC 35
741 ESCHERICHIA INFECTION 35
742 FOETAL GROWTH RESTRICTION 35
743 HEPATOCELLULAR DAMAGE 35
744 HYDROCEPHALUS 35
745 HYPERCHOLESTEROLAEMIA 35
746 MUSCLE CONTRACTIONS INVOLUNTARY 35
747 MYOGLOBINURIA 35
748 POLYNEUROPATHY 35
749 PROTEINURIA 35
750 RED BLOOD CELL COUNT DECREASED 35
751 THROMBOPHLEBITIS 35
752 BACTERIAL INFECTION 34
753 CATARACT 34
754 CHRONIC GASTRITIS 34
755 DISEASE COMPLICATION 34
756 DRUG EFFECT PROLONGED 34
757 END-TIDAL CO2 INCREASED 34
758 INTERVERTEBRAL DISC DEGENERATION 34
759 MUSCLE ATROPHY 34
760 OSTEONECROSIS OF JAW 34
761 PAIN IN JAW 34
762 PANCREATITIS NECROTISING 34
763 PNEUMOMEDIASTINUM 34
764 PRODUCT ADMINISTRATION ERROR 34
765 SNEEZING 34
766 SPUTUM INCREASED 34
767 VERTIGO 34
768 ACUTE LUNG INJURY 33
769 ADVERSE REACTION 33
770 ARTERIOSCLEROSIS 33
771 BLINDNESS 33
772 DEVICE RELATED INFECTION 33
773 HYPERAMMONAEMIC ENCEPHALOPATHY 33
774 HYPERCALCAEMIA 33
775 LYMPHOCYTE COUNT DECREASED 33
776 MALIGNANT NEOPLASM PROGRESSION 33
777 NEPHROLITHIASIS 33
778 NEUROLOGICAL SYMPTOM 33
779 OROPHARYNGEAL DISCOMFORT 33
780 PHAEOCHROMOCYTOMA CRISIS 33
781 POLLAKIURIA 33
782 PRESCRIBED OVERDOSE 33
783 PRINZMETAL ANGINA 33
784 SECRETION DISCHARGE 33
785 BRADYPNOEA 32
786 CHOLECYSTITIS 32
787 DRUG EFFECT INCOMPLETE 32
788 FLUID RETENTION 32
789 HYPERTHYROIDISM 32
790 HYPOCAPNIA 32
791 IMPAIRED HEALING 32
792 IMPAIRED WORK ABILITY 32
793 NEPHROPATHY TOXIC 32
794 PANIC ATTACK 32
795 PNEUMATOSIS 32
796 QUADRIPARESIS 32
797 RESPIRATORY ALKALOSIS 32
798 ANAL INCONTINENCE 31
799 ANTINUCLEAR ANTIBODY POSITIVE 31
800 ARTHROPATHY 31
801 BRONCHOPULMONARY ASPERGILLOSIS 31
802 CARDIAC DYSFUNCTION 31
803 DEAFNESS 31
804 HEAD INJURY 31
805 HEPATITIS TOXIC 31
806 HYPERPARATHYROIDISM SECONDARY 31
807 ILEUS PARALYTIC 31
808 INJECTION SITE SWELLING 31
809 INTESTINAL OBSTRUCTION 31
810 ISCHAEMIC HEPATITIS 31
811 MANIA 31
812 PHARYNGEAL OEDEMA 31
813 PHRENIC NERVE PARALYSIS 31
814 POOR QUALITY DRUG ADMINISTERED 31
815 SKIN LACERATION 31
816 SUPERINFECTION 31
817 TUMOUR LYSIS SYNDROME 31
818 VAGINAL HAEMORRHAGE 31
819 ABDOMINAL COMPARTMENT SYNDROME 30
820 AMMONIA INCREASED 30
821 BREATH SOUNDS ABNORMAL 30
822 CONJUNCTIVITIS 30
823 DYSGEUSIA 30
824 EMOTIONAL DISORDER 30
825 GLOMERULAR FILTRATION RATE DECREASED 30
826 HEART RATE IRREGULAR 30
827 HEPATORENAL FAILURE 30
828 INCONTINENCE 30
829 MALABSORPTION 30
830 RASH PUSTULAR 30
831 SKIN ULCER 30
832 SPLENOMEGALY 30
833 SUSPECTED PRODUCT QUALITY ISSUE 30
834 UNDERDOSE 30
835 BONE MARROW FAILURE 29
836 BURKHOLDERIA TEST POSITIVE 29
837 CONCOMITANT DISEASE AGGRAVATED 29
838 CROHN^S DISEASE 29
839 DERMATITIS EXFOLIATIVE 29
840 DIASTOLIC DYSFUNCTION 29
841 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29
842 ECONOMIC PROBLEM 29
843 ENTEROCOCCAL INFECTION 29
844 INTESTINAL PSEUDO-OBSTRUCTION 29
845 LARGE INTESTINE PERFORATION 29
846 LOWER RESPIRATORY TRACT INFECTION 29
847 METABOLIC ENCEPHALOPATHY 29
848 MONOPLEGIA 29
849 MUTISM 29
850 NEONATAL RESPIRATORY DEPRESSION 29
851 NERVE INJURY 29
852 PCO2 DECREASED 29
853 PNEUMOCOCCAL SEPSIS 29
854 PNEUMONIA STAPHYLOCOCCAL 29
855 SENSORY DISTURBANCE 29
856 SENSORY LOSS 29
857 SOPOR 29
858 STOMATITIS 29
859 VASODILATATION 29
860 AIR EMBOLISM 28
861 ANGINA PECTORIS 28
862 CHOLECYSTITIS ACUTE 28
863 CLONIC CONVULSION 28
864 CONJUNCTIVAL HYPERAEMIA 28
865 ECZEMA 28
866 FOETAL EXPOSURE DURING DELIVERY 28
867 GUILLAIN-BARRE SYNDROME 28
868 HYPERAEMIA 28
869 ISCHAEMIA 28
870 MUSCLE TIGHTNESS 28
871 MYOCARDIAL INJURY 28
872 POLYP 28
873 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28
874 PSEUDOMONAL SEPSIS 28
875 RESTLESS LEGS SYNDROME 28
876 THYROTOXIC CRISIS 28
877 WOUND 28
878 WOUND INFECTION 28
879 BLINDNESS TRANSIENT 27
880 CARDIAC TAMPONADE 27
881 CHOREA 27
882 CRYING 27
883 DISTRIBUTIVE SHOCK 27
884 DRUG LEVEL CHANGED 27
885 EMBOLIC STROKE 27
886 HICCUPS 27
887 HISTIOCYTOSIS HAEMATOPHAGIC 27
888 HOSPITALISATION 27
889 HYPORESPONSIVE TO STIMULI 27
890 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27
891 IRON DEFICIENCY 27
892 JOINT SWELLING 27
893 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 27
894 MACROGLOSSIA 27
895 PARKINSONISM 27
896 POST-TRAUMATIC STRESS DISORDER 27
897 SKIN LESION 27
898 SPINAL MUSCULAR ATROPHY 27
899 THROAT IRRITATION 27
900 WRONG DRUG ADMINISTERED 27
901 CONTINUOUS HAEMODIAFILTRATION 26
902 CYST 26
903 DRUG WITHDRAWAL SYNDROME NEONATAL 26
904 FIBRIN D DIMER INCREASED 26
905 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 26
906 HERPES ZOSTER 26
907 INCOHERENT 26
908 INSPIRATORY CAPACITY DECREASED 26
909 NEPHROPATHY 26
910 NEUROMYOPATHY 26
911 OSTEOMYELITIS 26
912 PLEOCYTOSIS 26
913 POSTOPERATIVE FEVER 26
914 QUADRIPLEGIA 26
915 RENAL CYST 26
916 SKIN REACTION 26
917 THERAPY CESSATION 26
918 UROSEPSIS 26
919 ANAL ABSCESS 25
920 APNOEIC ATTACK 25
921 ARTHRITIS 25
922 BLOOD PRESSURE ABNORMAL 25
923 CARBON DIOXIDE INCREASED 25
924 CARCINOID CRISIS 25
925 CEREBRAL DISORDER 25
926 CEREBRAL HAEMATOMA 25
927 CSF OLIGOCLONAL BAND PRESENT 25
928 DIVERTICULUM 25
929 DRUG LEVEL DECREASED 25
930 ENDOCARDITIS 25
931 ESCHERICHIA BACTERAEMIA 25
932 EYE PAIN 25
933 HYPOXIC ENCEPHALOPATHY 25
934 JOINT DISLOCATION 25
935 LUNG INFECTION 25
936 MYASTHENIA GRAVIS 25
937 NIGHTMARE 25
938 OBSTRUCTIVE SLEEP APNOEA SYNDROME 25
939 OLIGOHYDRAMNIOS 25
940 OSTEOPENIA 25
941 OSTEOPOROSIS 25
942 PERFORATION 25
943 PERFORMANCE STATUS DECREASED 25
944 PETECHIAE 25
945 RESPIRATORY TRACT INFECTION BACTERIAL 25
946 ROAD TRAFFIC ACCIDENT 25
947 SCAR 25
948 STAPHYLOCOCCAL SEPSIS 25
949 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 25
950 SYSTOLIC DYSFUNCTION 25
951 ACUTE POSTOPERATIVE SIALADENITIS 24
952 ANAESTHETIC COMPLICATION CARDIAC 24
953 AORTIC VALVE INCOMPETENCE 24
954 AZOTAEMIA 24
955 BLOOD DISORDER 24
956 BLOOD PHOSPHORUS INCREASED 24
957 BLOOD PRESSURE DIASTOLIC DECREASED 24
958 BLOOD SODIUM DECREASED 24
959 BONE DISORDER 24
960 CEREBRAL ATROPHY 24
961 CONFUSION POSTOPERATIVE 24
962 COORDINATION ABNORMAL 24
963 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 24
964 DRUG EFFECT LESS THAN EXPECTED 24
965 ENTEROCOLITIS 24
966 EUGLYCAEMIC DIABETIC KETOACIDOSIS 24
967 FAECES DISCOLOURED 24
968 HYPOPERFUSION 24
969 IMPAIRED GASTRIC EMPTYING 24
970 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 24
971 INTRACARDIAC THROMBUS 24
972 LEUKOENCEPHALOPATHY 24
973 LIVEDO RETICULARIS 24
974 MEAN ARTERIAL PRESSURE DECREASED 24
975 NEUTROPHIL COUNT INCREASED 24
976 PERIORBITAL SWELLING 24
977 PLATELET COUNT INCREASED 24
978 POSTPARTUM HAEMORRHAGE 24
979 PRESYNCOPE 24
980 PRODUCT PACKAGING CONFUSION 24
981 PULMONARY ARTERIAL HYPERTENSION 24
982 SKIN DISORDER 24
983 TARDIVE DYSKINESIA 24
984 TRACHEAL DEVIATION 24
985 WEIGHT BEARING DIFFICULTY 24
986 ACCIDENTAL DEATH 23
987 BILIRUBIN CONJUGATED INCREASED 23
988 BODY TEMPERATURE DECREASED 23
989 BRONCHIAL DISORDER 23
990 COLD SWEAT 23
991 CONGESTIVE HEPATOPATHY 23
992 CREATININE RENAL CLEARANCE DECREASED 23
993 DEVICE FAILURE 23
994 DIABETIC KETOACIDOSIS 23
995 DRY EYE 23
996 EXTRA DOSE ADMINISTERED 23
997 INJECTION SITE REACTION 23
998 INTERVERTEBRAL DISC PROTRUSION 23
999 LABORATORY TEST ABNORMAL 23